NDC 50228-459 – Carbidopa and Levodopa

Carbidopa 25 mg/1; Levodopa 250 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC50228-459

Product details

Brand name
Carbidopa and Levodopa
Generic name
Carbidopa and Levodopa
Labeler
ScieGen Pharmaceuticals Inc
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA214092
Marketed since
May 7, 2021
Listing expires
December 31, 2027
Pharmacologic class
Aromatic Amino Acid

Active ingredients

Uses, dosage, side effects and warnings for Carbidopa and Levodopa →

Package NDC codes (4)

Package NDCDescriptionSince
50228-459-01100 TABLET in 1 BOTTLE (50228-459-01)May 7, 2021
50228-459-05500 TABLET in 1 BOTTLE (50228-459-05)May 7, 2021
50228-459-101000 TABLET in 1 BOTTLE (50228-459-10)May 7, 2021
50228-459-3030 TABLET in 1 BOTTLE (50228-459-30)May 7, 2021

Other Carbidopa and Levodopa products